Renoprotection in LEADER and EMPA-REG OUTCOME

Autor:	Erik J M van Bommel, Daniël H. van Raalte, Lennart Tonneijck, Marcel H.A. Muskiet, Mark M. Smits
Přispěvatelé:	Internal medicine, ICaR - Circulation and metabolism
Jazyk:	angličtina
Rok vydání:	2016
Předmět:	Sodium glucose transporter 2 business.industry Endocrinology Diabetes and Metabolism 030209 endocrinology & metabolism 030204 cardiovascular system & hematology Pharmacology Outcome (game theory) 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Endocrinology Diabetes Mellitus Type 2 Glucosides Sodium-Glucose Transporter 2 chemistry Cardiovascular Diseases Internal Medicine Humans Hypoglycemic Agents Medicine Benzhydryl compounds Benzhydryl Compounds business EMPA
Zdroj:	Lancet diabetes & endocrinology, 4(10), 812-4. Elsevier BV ResearcherID Muskiet, M H A, Tonneijck, L, van Bommel, E J M, Smits, M M & van Raalte, D H 2016, ' Renoprotection in LEADER and EMPA-REG OUTCOME ', Lancet diabetes & endocrinology, vol. 4, no. 10, pp. 812-4 . https://doi.org/10.1016/S2213-8587(16)30214-5
ISSN:	2213-8587
DOI:	10.1016/s2213-8587(16)30214-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::498b02d7d6f2ce9542625d1b78e1cd04 https://doi.org/10.1016/s2213-8587(16)30214-5 Zobrazit plný text záznamu